Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Intec Pharma (NTEC) IPO Opens Flat
August 4, 2015 10:03 AM EDTToday's IPO for Intec Pharma (NASDAQ: NTEC) opened for trading at $6.00 per share, after pricing 5,025,000 of its ordinary shares at a price to the public of $6.00 per ordinary share.
Maxim Group LLC and Roth Capital Partners are acting as joint book-running... More
Intec Pharma (NTEC) Prices 5.03M Ordinary Share IPO at $6/Share
August 4, 2015 9:28 AM EDTIntec Pharma Ltd. (the "Company") (Nasdaq: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, announced the pricing of its initial public offering in the United States of 5,025,000 of its ordinary shares at a price to the public of $6.00 per ordinary share, before... More
